Protagenic Therapeutics, Inc. Major Shareholders & Ownership History
| Major Shareholder Name | Reporting Date | Shares Held | Market Value | Change in Shares | Ownership |
|---|---|---|---|---|---|
| WARBERG ASSET MANAGEMENT LLC | 05/09/2025 | 170.24 K | $1.28 K | 0.00% | 32.54% |
| CLEAR STREET LLC | 05/15/2025 | 100.00 K | $750 | 100.00% | 19.11% |
| SUSQUEHANNA INTERNATIONAL GROUP, LLP | 05/14/2025 | 50.18 K | $376 | -25.29% | 9.59% |
| GTS SECURITIES LLC | 05/15/2025 | 25.30 K | $202 | -0.39% | 4.84% |
| UBS GROUP AG | 05/13/2025 | 3.00 K | $21 | 733.33% | 0.57% |
| TWO SIGMA SECURITIES, LLC | 05/15/2025 | 0 | $0 | -100.00% | 0.00% |
Explore Related Stocks for Market Trends
Explore our related stocks for the latest market trends and stock news to stay informed and make better decisions.
Protagenic Therapeutics, Inc. institutional Ownership - FAQ's
During the previous two years, 6 institutional investors and hedge funds held shares of Protagenic Therapeutics, Inc.. The most heavily invested institutionals were:
Warberg Asset Management LLC: 170,242
CLEAR STREET LLC: 100,000
SUSQUEHANNA INTERNATIONAL GROUP, LLP: 50,184
GTS SECURITIES LLC: 25,300
UBS Group AG: 3,000
TWO SIGMA SECURITIES, LLC: 0
66.65% of Protagenic Therapeutics, Inc. stock is owned by institutional investors.
Institutional investors have bought a total of 348.73 K shares in the last 24 months. This purchase volume represents approximately $20.92 K in transactions.